ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 90 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $19,396,000 | -66.4% | 1,300,000 | -42.1% | 0.00% | -70.0% |
Q3 2021 | $57,737,000 | -1.5% | 2,246,576 | -0.0% | 0.01% | 0.0% |
Q2 2021 | $58,591,000 | -26.1% | 2,246,577 | -0.0% | 0.01% | -33.3% |
Q1 2021 | $79,305,000 | +32.5% | 2,246,603 | -5.3% | 0.02% | +25.0% |
Q4 2020 | $59,865,000 | -40.4% | 2,371,817 | -11.0% | 0.01% | -45.5% |
Q3 2020 | $100,523,000 | -32.6% | 2,665,686 | -23.4% | 0.02% | -38.9% |
Q2 2020 | $149,062,000 | +157.5% | 3,481,124 | +16.9% | 0.04% | +111.8% |
Q1 2020 | $57,886,000 | -25.2% | 2,977,664 | 0.0% | 0.02% | 0.0% |
Q4 2019 | $77,360,000 | -13.4% | 2,977,664 | -9.1% | 0.02% | -22.7% |
Q3 2019 | $89,279,000 | +19.8% | 3,275,685 | +18.1% | 0.02% | +29.4% |
Q2 2019 | $74,497,000 | +18.7% | 2,774,581 | +27.8% | 0.02% | +13.3% |
Q1 2019 | $62,778,000 | +7.4% | 2,171,483 | 0.0% | 0.02% | -6.2% |
Q4 2018 | $58,478,000 | – | 2,171,483 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |